Get the App
A

Arbutus Biopharma (ABUS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Arbutus Biopharma (ABUS)

Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more

  • 2.45
  • 2.55
  • 2.38
  • 4.67
  • 6%
  • 46M
  • 519.97k
  • 1.18M
  • 388M
  • 1.85
  • -42.5%
  • %

Stock News

The Moneyist: ‘This guy grifted me hard’: My date chose an exclusive L.A. restaurant. After dinner, he accepted my credit card — and we split a $600 bill. Shouldn’t he have paid?

1 hour ago

The Moneyist: ‘This guy grifted me hard’: My date chose an exclusive L.A. restaurant. After dinner, he accepted my credit card — and we split a $600 bill. Shouldn’t he have paid?

MarketWatch

Retire Better: This one great idea can make everyone better with money, older Americans say

1 hour ago

Retire Better: This one great idea can make everyone better with money, older Americans say

MarketWatch

These Are the 89 Best Restaurants in California, Says Michelin Guide

2 hours ago

These Are the 89 Best Restaurants in California, Says Michelin Guide

Bloomberg

Dow Jones Newswires: Australia’s central bank raises rates, says path to soft landing is narrow

3 hours ago

Dow Jones Newswires: Australia’s central bank raises rates, says path to soft landing is narrow

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium